Today it is a fintech star on the rise and potentially on the verge of disrupting the U.S. retail sector.
With that in mind, I thought I would take a look at a few small cap shares which are flying under the radar today.
Three that I like the look of are listed below, though it is worth remembering that all are reasonably high risk investments:
Citadel Group Ltd (ASX: CGL)
I think that Citadel Group is a company with significant potential. It is a fast-growing software and services company providing integration and managed services solutions to state and federal governments and the private sector in Australia. It is profitable, has strong growth potential, and holds little debt on its balance sheet.
ELMO Software Ltd (ASX: ELO)
ELMO is a leading provider of integrated cloud human resources and payroll software solutions. Its SaaS, cloud-based platform provides businesses with a centralised approach to managing an employee’s lifecycle from hire to retire. ELMO has really caught the eye this year thanks to its stellar earnings growth. So much so, it looks set to smash its prospectus forecasts again in FY 2018. The good news is that I don’t think it is too late to invest. Especially with management estimating the ANZ market opportunity to be worth upwards of US$770 million per year.
LiveTiles Ltd (ASX: LVT)
LiveTiles is a fast-growing digital workplace platform provider with eyes on the massive AI market. It recently revealed a significant lift in annualised recurring revenues (ARR) thanks largely to its ties with tech giant Microsoft and investment in sales and marketing. According to the update, ARR reached $15 million as of June 30, up 275% on the prior corresponding period. In addition to this, LiveTiles was recently awarded the 2018 Microsoft US Partner of the Year Award for Modern Workplace Transformation. I think this award is a testament to the quality of its offering.
The ASX small cap up 285% with no sign of stopping...
One Australian company has developed a state of the art device that's revolutionizing hospitals all over the world. Even better, this device is so profitable that the company rakes in 90% margins. That's a lot of cash. So no wonder the stock's up 285% since 2008 – with no signs of stopping...
To discover the name and code, simply click the link below. You'll discover our expert's #1 medical technology pick... and you can decide for yourself whether to get invested today.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended ELMOSFTWRE FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO and Citadel Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.